Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Bullboard Posts
Post by Greencashon Jun 05, 2018 9:58am
29 Views
Post# 28125239

Canadians will spend up to $7B on cannabis in 2019, Deloitte

Canadians will spend up to $7B on cannabis in 2019, Deloitte

Canadians will spend up to $7B on cannabis in 2019, Deloitte predicts

Between $500M and $1B of those sales expected to be illegal, report says

 
A new report from accounting firm Deloitte predicts Canadians will significantly increase their cannabis consumption when it's legalized. (David Donnelly/CBC)

After cannabis is legalized throughout Canada later this year, Canadians are expected to increase their consumption of the drug by up to 35 per cent and spend as much as $7 billion on legal and illegal sales in 2019.

Accounting firm Deloitte makes those predictions in a new report based on an online survey of 1,500 adults living in Canada's 10 provinces conducted between March 6 and March 20. The survey didn't include residents of territories.

Legal cannabis sales are expected to reach up to $4.34 billion, while illegal sales could be anywhere from $510 million to $1.04 billion, and medical cannabis could account for between $770 million and $1.79 billion of the market, the report says.

People who already consume cannabis ahead of legalization — who tend to be 18 to 34 years old and use it multiple times per week — are expected to start making about 63 per cent of their purchases legally, despite having to pay what Deloitte anticipates will be about 10 cents more per gram after legalization.

 
Deloitte conducted an online survey of 1,500 adults in Canada's provinces in March. (Hannah McKay/Reuters)

"Over time, as retailers develop a better understanding of their customers' needs and behaviours, improve their customer experience and engagement programs, and fine-tune their products' quality and integrity, we could expect to see an increasing share of cannabis sales transition to legal sources," the report says.

Other findings

  • Legalization is expected to bring more 35- to 54-year-olds into the market. They'll be more likely to consume the drug less than once per month, the report says.
  • Most people in the West, Ontario and the Atlantic provinces are expected to buy cannabis through legal channels (66, 65 and 55 per cent, respectively), while in Quebec, most people are expected to buy cannabis illegally (53 per cent).
  • Six of every 10 cannabis users will choose edible forms of the drug, which won't be available through legal channels for at least a year after legalization.

 

 

 
Bullboard Posts